Washington Institute For Coagulation

The Washington Institute For Coagulation is a non-profit organization registered in SAM.gov since 2019, specializing in providing blood products, pharmaceuticals, and medical supplies related to bleeding disorders. Located in Seattle, Washington, the organization operates through its Washington Center for Bleeding Disorders Division and focuses on supporting healthcare services for patients with complex blood-related medical conditions. The institute primarily serves federal agencies, with a strong emphasis on delivering specialized medical products and participating in regional healthcare networks.

Through federal contract awards, Washington Institute For Coagulation has consistently provided blood-related medical products and services to the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 20 (VISN 20). The organization has been awarded multiple contracts for delivering blood products, blood factor products, hemophilia medications, and blood disorder treatments. These contracts have ranged in value from $16,476.52 to $200,000, with performance periods extending through September 2027. All contract awards have been firm fixed price purchase orders or delivery orders, and none have been set aside for specific socioeconomic categories. The contracts primarily support healthcare services for veterans in the Seattle, Washington area, demonstrating the institute's commitment to providing specialized medical supplies to support veteran healthcare needs.

In terms of grant activities, Washington Institute For Coagulation has participated as a sub-grantee in the Regional Hemophilia Network for the Mountain States region. These sub-grant awards, consistently associated with Oregon Health & Science University as the prime grantee, have been ongoing since at least 2021. The sub-grants focus on supporting regional hemophilia networks, indicating the organization's involvement in collaborative healthcare initiatives aimed at improving medical support and resources for individuals with hemophilia and related bleeding disorders.

The institute holds a single award indefinite delivery contract (IDV) with the VA Veterans Health Administration, valued at $264,000, which expires on September 29, 2024. This IDV allows for the provision of blood products and blood disorder medications to support veteran healthcare services within Veterans Integrated Service Network 20. Under this contract, two specific delivery orders have been issued: one valued at $125,000 for blood products and another at $50,000 for unspecified blood disorder medications. Both delivery orders have performance periods extending through September 2027 and are located in Seattle, Washington. The IDV enables the Washington Institute For Coagulation to deliver specialized medical supplies that support the VA's mission of providing comprehensive healthcare to veterans.